Ocular Therapeutix
OCUL
OCUL
149 hedge funds and large institutions have $1.04B invested in Ocular Therapeutix in 2020 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
38% more funds holding
Funds holding: 108 → 149 (+41)
37% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 35
3.8% more ownership
Funds ownership: 63.18% → 66.98% (+3.8%)
Holders
149
Holding in Top 10
10
Calls
$12.3M
Puts
$4.96M
Top Buyers
| 1 | +$29.6M | |
| 2 | +$24.6M | |
| 3 | +$23.2M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$22.5M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$17.7M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$21.4M | |
| 3 | -$15.5M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$11.3M |
| 5 |
DAM
Deltec Asset Management
New York
|
-$6.28M |